Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to announce that six researchers have been awarded the Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.

Our new Professors are:

  • Geraldine Gillespie, awarded the title of Professor of Molecular Immunology at the Centre for Immuno-oncology
  • Direk Limmathurotsakul, awarded the title of Professor of Infectious Disease Epidemiology at the Mahidol-Oxford Tropical Medicine Research Unit (MORU)
  • Emelda Okiro, awarded the title of Professor of Global Health at the KEMRI-Wellcome Trust Research Programme
  • Jenny Taylor, awarded the title of Professor of Translational Genomics at the Wellcome Centre for Human Genetics
  • Rogier Van Doorn, awarded the title of Professor of Infectious Diseases at the Oxford University Clinical Research Unit (OUCRU)
  • Richard White, awarded the title of Professor of Genetics at the Ludwig Institute for Cancer Research

Many congratulations to all!

Similar stories

Rift Valley fever vaccine to enter Phase II clinical trials in Kenya

A promising human vaccine candidate against the potentially deadly Rift Valley fever, a mosquito-borne disease affecting countries across Africa, is set to begin Phase II trials in Kenya. This is the most advanced stage of testing a human Rift Valley fever vaccine has reached in an outbreak-prone area to date. A team of scientists at the Nuffield Department of Medicine and the KEMRI-Wellcome Trust Research Programme will lead the $3.7m trial, funded by the Coalition for Epidemic Preparedness Innovations (CEPI).